Wheelchairs News and Research

RSS

NYSCF and Beyond Batten Disease Foundation partner to find cure for juvenile Batten disease

The New York Stem Cell Foundation (NYSCF) and Beyond Batten Disease Foundation (BBDF) have partnered to develop stem cell resources to investigate and explore new treatments and ultimately find a cure for juvenile Batten disease, a fatal illness affecting children.

24 Jul 2014

Viewpoints: Problems in training docs; impact of HHS' territory decision; what Halbig decision might mean

ast week's burst of world disorder was ideal for a news dump, and the White House didn't disappoint: On no legal basis, all 4.5 million residents of the five U.S. territories were quietly released from ObamaCare.

22 Jul 2014

Advocacy group publicizes child deaths from accidental shootings

Almost two children a week were killed in unintentional shootings during the 12 months that followed the shooting at Sandy Hook Elementary School, according to a report by the gun control group Everytown for Gun Safety.

28 Jun 2014

State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

A selection of health policy stories from Ohio, Oregon, New York, Colorado, Iowa, New Jersey, North Carolina, Georgia, California and Minnesota.

24 Jun 2014

State highlights: N.Y. lawmakers deal on heroin abuse; N.Y. birth control discrimination bill; nursing home costs in Mich.

A selection of health policy stories from New York, Michigan, New Jersey, Virginia, Maryland, North Carolina, California, Texas, Washington state, Missouri, Massachusetts and Colorado.

20 Jun 2014

VA scandal prompts closer look at VA health care around nation

News outlets examine wait times and poor service at clinics in North Carolina, Colorado and Minnesota.

18 Jun 2014

First Edition: June 17, 2014

Today's headlines include developments related to the health care marketplace and state health policy.

17 Jun 2014

State highlights: New La. abortion restrictions; new Mass. hospital deal; Medicare and ambulances in N.J.

A selection of health policy stories from Louisiana, Massachusetts, New Jersey, Wisconsin, Georgia, Missouri, Maryland, New York, Kansas and Washington state.

16 Jun 2014

BRI researchers use tetramer technology to find T cells that drive rheumatoid arthritis

Researchers at Benaroya Research Institute at Virginia Mason used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA). "By using tetramer technology, we were able to examine whether T cells in people with rheumatoid arthritis were increased in number or were unique in other ways," says BRI Associate Director Jane Buckner, MD, who led the study with BRI Tetramer Core Laboratory Manager Eddie James, PhD.

12 Jun 2014

Liposuction expert offers treatment for patients suffering from lipedema

Liposuction expert Dr. David Amron is one of the select surgeons in the nation to successfully treat lipedema (a.k.a. lipoedema), a potentially debilitating condition that causes abnormal accumulation of fat cells in the legs and sometimes arms.

6 Jun 2014

United Spinal Association, NSCIA to convene at ROCH to address disability issues

United Spinal Association and advocates from its membership division, National Spinal Cord Injury Association (NSCIA), will gather in Washington, D.C. on June 22-25 for Roll on Capitol Hill to shape policies that impact the health, independence and quality of life of people living with spinal cord injuries and disorders (SCI/D).

6 Jun 2014

Novel technology to block human infections receives I-Corps grant

A novel technology developed at Worcester Polytechnic Institute (WPI) to block human infections by taking a lesson from fish has landed a $50,000 grant from the National Science Foundation's Innovation Corps (I-Corps) program.

5 Jun 2014

HAL robot suit helps paraplegics

For most paraplegic patients, being able to walk again remains a dream. The HAL robot suit can help them regain a certain degree of mobility and activity. An expert team at the Centre for Neurorobotic Movement Training (ZNB) in Bochum has been testing the exoskeleton that was originally developed in Japan since 2011. With excellent results.

20 May 2014

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

A new subcutaneous formulation of RoActemra® (tocilizumab) has today been launched providing thousands of UK rheumatoid arthritis (RA) patients with a potentially life-changing treatment option.1

19 May 2014

New potential treatment for paraplegic patients

People with severe injuries to their spinal cord currently have no prospect of recovery and remain confined to their wheelchairs. Now, all that could change with a new treatment that stimulates the spinal cord using electric impulses.

16 May 2014

State highlights: Missouri Medicaid benefits; telepsychiatry in rural states; Conn. for-profit hospital bill

A selection of health policy stories from Missouri, North Carolina, Connecticut, Georgia, Minnesota, Michigan and Alaska.

9 May 2014

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

A drug typically prescribed for erectile dysfunction or increased pressure in the arteries may help improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to a study published in the May 7, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 May 2014

Standard test that measures everyday activities may help prevent rapid return to inpatient care

Patients freshly discharged from acute care hospitals with low scores on a standard test that measures how well they perform such everyday activities as moving from a bed to a chair are far more likely to need readmission to a hospital within 30 days than those who score better, according to new Johns Hopkins research.

6 May 2014

Longer looks: Terri Schiavo case; stem cell tourism in China; fall protection for the elderly

Increasingly, Big Pharma is betting on new blockbuster cancer drugs that cost billions to develop and can be sold for thousands of dollars a dose. In 2010, each of the top 10 cancer drugs topped more than $1 billion in sales, according to Campbell Alliance, a health-care consulting firm. A decade earlier, only two of them did.

25 Apr 2014

U.Va. researchers named recipients of 2013 Hartwell Individual Biomedical Research Awards

University of Virginia neurologist Dr. Erin Pennock Foff, biologist Sarah Kucenas and biomedical engineer Shayn Peirce-Cotter have been named recipients of 2013 Hartwell Individual Biomedical Research Awards to benefit children of the United States. Each scientist will receive $100,000 in direct annual research support from The Hartwell Foundation for three years.

19 Apr 2014